| Michael Barychewsky, CRNA | |
|
1 Cooper Plz, Camden, NJ 08103-1461 | |
| (856) 342-2425 | |
| (856) 968-8326 |
| Full Name | Michael Barychewsky |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 19 Years |
| Location | 1 Cooper Plz, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386614667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 25NJ00702900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Atlanticare Regional Medical Center | Atlantic city, NJ | Hospital |
| Cape Regional Medical Center Inc | Cape may court house, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlanticare Regional Medical Center | 0648181578 | 85 |
| Cooper Anesthesia Associates Pc | 1254236672 | 162 |
| Parkway Anesthesia Associates Llc | 2567758931 | 126 |
| New Jersey Healthcare Specialists Pc | 2668385253 | 554 |
News Archive
CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
Motor vehicle crashes are a leading cause of death among children despite the widespread availability of effective child passenger restraint systems (CPRSs) such as child safety seats. However, even when provided with free CPRSs and education about how to use them properly, many caregivers do not make them a part of their daily routine, according to the authors of a new study published in the Wisconsin Medical Journal (Vol. 108, No. 7).
Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.
› Verified 5 days ago
| Entity Name | New Jersey Healthcare Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174585780 PECOS PAC ID: 2668385253 Enrollment ID: O20031110000555 |
News Archive
CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
Motor vehicle crashes are a leading cause of death among children despite the widespread availability of effective child passenger restraint systems (CPRSs) such as child safety seats. However, even when provided with free CPRSs and education about how to use them properly, many caregivers do not make them a part of their daily routine, according to the authors of a new study published in the Wisconsin Medical Journal (Vol. 108, No. 7).
Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.
› Verified 5 days ago
| Entity Name | Cooper Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447207147 PECOS PAC ID: 1254236672 Enrollment ID: O20031126000651 |
News Archive
CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
Motor vehicle crashes are a leading cause of death among children despite the widespread availability of effective child passenger restraint systems (CPRSs) such as child safety seats. However, even when provided with free CPRSs and education about how to use them properly, many caregivers do not make them a part of their daily routine, according to the authors of a new study published in the Wisconsin Medical Journal (Vol. 108, No. 7).
Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.
› Verified 5 days ago
| Entity Name | Atlanticare Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710930102 PECOS PAC ID: 0648181578 Enrollment ID: O20040212000251 |
News Archive
CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
Motor vehicle crashes are a leading cause of death among children despite the widespread availability of effective child passenger restraint systems (CPRSs) such as child safety seats. However, even when provided with free CPRSs and education about how to use them properly, many caregivers do not make them a part of their daily routine, according to the authors of a new study published in the Wisconsin Medical Journal (Vol. 108, No. 7).
Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.
› Verified 5 days ago
| Entity Name | Parkway Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518319755 PECOS PAC ID: 2567758931 Enrollment ID: O20160912000258 |
News Archive
CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
Motor vehicle crashes are a leading cause of death among children despite the widespread availability of effective child passenger restraint systems (CPRSs) such as child safety seats. However, even when provided with free CPRSs and education about how to use them properly, many caregivers do not make them a part of their daily routine, according to the authors of a new study published in the Wisconsin Medical Journal (Vol. 108, No. 7).
Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.
› Verified 5 days ago
| Entity Name | Rwjbh Observation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
Motor vehicle crashes are a leading cause of death among children despite the widespread availability of effective child passenger restraint systems (CPRSs) such as child safety seats. However, even when provided with free CPRSs and education about how to use them properly, many caregivers do not make them a part of their daily routine, according to the authors of a new study published in the Wisconsin Medical Journal (Vol. 108, No. 7).
Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Barychewsky, CRNA 1 Federal St Ste 200, Camden, NJ 08103-1088 Ph: (848) 288-6935 | Michael Barychewsky, CRNA 1 Cooper Plz, Camden, NJ 08103-1461 Ph: (856) 342-2425 |
News Archive
CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
Motor vehicle crashes are a leading cause of death among children despite the widespread availability of effective child passenger restraint systems (CPRSs) such as child safety seats. However, even when provided with free CPRSs and education about how to use them properly, many caregivers do not make them a part of their daily routine, according to the authors of a new study published in the Wisconsin Medical Journal (Vol. 108, No. 7).
Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.
› Verified 5 days ago
Winter E. Skelly, CRNA, APN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz Dept Of, Camden, NJ 08103 Phone: 856-342-2425 | |
Balaishe Boakai Ballo, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3500 | |
Michael Phillip Hoess, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 | |
Amy Tsao, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Cooper Plz Dept Of, Camden, NJ 08103 Phone: 856-382-6500 | |
Maria Dinnah Eclavia-dy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Cooper Anesthesia Associates, Camden, NJ 08103 Phone: 856-342-2425 | |
Meredith Christina Defusco, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 | |
Amber Klein, APN-A CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3500 |